Filing Flows › Accustem Sciences (ACUT) › Q2 2026
Accustem Sciences (ACUT) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 14, 2026
Accustem Sciences (ACUT) reported revenue of $98K for the second quarter 2026 (Q2 2026). Operating margin was -256.7%, net loss $253K (256.7% of revenue).
Accustem Sciences, Q2 2026: revenue $98K, operating margin -256.7%, net loss $253K, operating cash flow −$249K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $98K | — | — |
| Operating profit | −$253K | — | — |
| Net earnings | −$253K | — | — |
| Operating cash flow | −$249K | — | — |
What changed
Revenue was $98K in Q2 2026.
Operating costs exceeded revenue by $253K, an operating margin of -256.7%. The quarter ended with a net loss of $253K.
Operating cash flow was −$249K. Non-cash charges added back $7K of share-based compensation.
Questions
What was Accustem Sciences' revenue in the second quarter 2026?
Accustem Sciences (ACUT) reported revenue of $98K for the second quarter 2026 (Q2 2026).
Was Accustem Sciences profitable in the second quarter 2026?
Operating loss was $253K (-256.7% of revenue) and net loss $253K.
Source: Accustem Sciences 10-Q on SEC EDGAR.